Surgical Stapler Lawsuit News:
Recalls, FDA Reclassification & New Consolidated Federal Case
The FDA’s reclassification of surgical staplers as Class II devices triggered a wave of new filings. A major consolidated action in the Central District of California is in active discovery — with hidden adverse-event data now being compelled from the FDA’s alternative reporting system. Our firm is accepting cases nationwide.
Key Federal Action & Discovery Orders
Where the Litigation Stands Now
A major consolidated federal action is underway in the Central District of California, where several motions to dismiss have been denied and a Master Case Management Order is now compelling production of documents that were previously hidden from public view.
In re: Surgical Stapler Products Liability Litigation
Case No. 8:25-cv-01911 — Central District of California
Motions to dismiss denied — defective design, manufacturing defect, and failure-to-warn claims all proceeding. The court’s Master Case Management Order (late 2025) requires production of adverse-event data previously hidden in the FDA’s alternative summary reporting system, internal failure-rate analyses, design-change documentation, surgeon complaint logs, and recall-related communications.
Parallel State-Court Coordinated Proceedings
California, Illinois & Pennsylvania State Courts
State-court actions in three major jurisdictions have been coordinated for discovery, expanding the evidentiary record and applying simultaneous pressure on manufacturers across multiple fronts.
Master CMO Requires Production Of:
- Hidden adverse-event data — failure reports previously buried in the FDA’s alternative summary reporting system, kept out of the public MAUDE database
- Internal failure-rate analyses — manufacturer records showing what defect and malfunction rates they tracked internally across product lines
- Design-change documentation — evidence of when and why design modifications were made, revealing manufacturer knowledge of prior defects
- Surgeon complaint logs — records of complaints received directly from operating surgeons about device performance
- Recall-related communications — internal and FDA communications surrounding past and ongoing recalls
Named Defendants
Which Manufacturers Are Being Sued?
The litigation targets the three largest surgical stapler manufacturers, whose products are used in millions of surgeries annually across nearly every surgical specialty. The FDA’s reclassification of these devices as Class II has brought renewed scrutiny to their design and safety controls.
What Plaintiffs Allege
How Surgical Staplers Failed Patients & What Manufacturers Concealed
Plaintiffs allege a dual failure: devices that malfunctioned during surgery in life-threatening ways, paired with manufacturer conduct that kept the true failure rate hidden from the surgeons relying on them.
Misfiring & Incomplete Stapling
Devices misfired or formed incomplete staple lines during surgery, leaving internal tissue connections unsealed and creating immediate risk of leakage, bleeding, and infection.
Anastomotic Leaks
Failed staple lines caused anastomotic leaks — leakage at surgical connection points — leading to peritonitis, sepsis, and emergency reoperation in severe cases.
Internal Bleeding
Incomplete staple formation left blood vessels inadequately sealed, causing internal hemorrhage that in some cases required emergency intervention.
Concealed Failure Rates
Manufacturers used the FDA’s alternative summary reporting system to file aggregate, non-specific reports rather than individual device-failure reports — keeping the true failure rate invisible to surgeons and patients.
Failure to Warn Surgeons
Surgeons were not provided with adequate warnings about known failure modes, leaving them unable to take precautions or counsel patients on the true risks of stapler-dependent procedures.
Defective Materials & Design
Plaintiffs allege the devices were manufactured with defective materials or designed with inherent flaws that caused malfunction under foreseeable surgical conditions.
Eligibility
Are You a Victim? Who May Qualify?
You may qualify if you underwent a surgical procedure in which a stapler was used and subsequently experienced a complication consistent with device malfunction. Both patients who required emergency reoperation and those with ongoing complications may be eligible.
Qualifying Complications
- Stapler misfire during surgery
- Anastomotic leak or staple line failure
- Internal bleeding from incomplete stapling
- Organ perforation linked to device failure
- Sepsis following stapler malfunction
- Emergency reoperation to correct stapler failure
- Permanent injury from device-related complication
General Eligibility Factors
- Underwent surgery using an Ethicon, Medtronic/Covidien, or 3M/KCI stapler
- Experienced a qualifying complication during or after surgery
- Complication documented in operative or post-operative records
- Required additional hospitalization, surgery, or treatment
Legal Theories & Damages
Liability & What You Can Recover
Liability Legal Theories
- Defective design
- Manufacturing defect
- Failure to warn
- Negligent recall
- Fraudulent concealment of failure data
- Breach of warranty
Damages What You Can Recover
- Medical bills (past and future)
- Lost wages and reduced earning capacity
- Compensation for permanent disability
- Pain and suffering
- Emotional distress
- Wrongful death damages
Our Firm Is Now Accepting Surgical Stapler Cases
We represent patients nationwide harmed by defective surgical staplers. We track every development in the Central District of California consolidated action, state coordinated proceedings, and FDA recall activity — to ensure our clients benefit from the evidence being produced and are positioned for maximum recovery.
We handle these cases on a contingency fee basis — you pay nothing unless we win.